Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Database Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Development Platform AlfaOPA
Applications
Druggability Assessment
Biopharmaceuticals
Synthetic Biology
IVD
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
中文
English
快速查找
产品服务
产品服务
产品服务
Global
Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Database Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Development Platform AlfaOPA
Applications
Druggability Assessment
Biopharmaceuticals
Synthetic Biology
IVD
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
Global
中文
English
Chairman of Great Bay Bio was Interviewed by InvestHK
2023-10-26
Back
Next
Related News
Great Bay Bio Enterprise Promotional Video
Great Bay Bio Attended BPI US 2023
CEO of Great Bay Bio explains the AlfaOPA platform at the new product launch conference
Great Bay Bio Attended HK ASGH 2023
Great Bay Bio Attended BEYOND Expo 2023
Michael Chen, CEO and co-founder of Great Bay Bio, attended the 2023 Future Medical Top 100 Conference Roundtable
GBB Presented the Commercialized SSI Technology on BPI US West
GBB’s Chairman Won HK Innopreneur Awards – GBA+ Award
Share
Message
